- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00359931
Brain Imaging of Tinnitus
Neural Modeling and Brain Imaging of Tinnitus
This study will use magnetic resonance imaging (MRI) to compare brain function in three groups of people: hearing-impaired people with tinnitus; hearing-impaired people without tinnitus; and people with normal hearing and without tinnitus. Also known as "ringing in the ears," tinnitus is the false sensation of sounds.
Adults between 30 and 65 years of age who meet the following criteria may be eligible for this study:
- Mild to moderate hearing loss who have experienced tinnitus daily for at least 1 year
- Mild to moderate hearing loss who have never or rarely experienced tinnitus
- Normal hearing who have never or rarely experienced tinnitus
Candidates are screened with a medical history and questionnaires.
Participants have a detailed hearing test to measure hearing and the nature of tinnitus. In a second visit, subjects have a brief physical examination, followed by MRI scanning. MRI uses a magnetic field and radio waves to produce images of body tissues and organs. For this procedure, the subject lies on a table that can slide in and out of the scanner (a narrow cylinder), wearing earplugs to muffle loud knocking and thumping sounds that occur during the scanning process. The subject may be asked to lie still for up to 8 minutes at a time. During the MRI, the subject performs computer-based tasks that involve listening to sounds. Another hearing test is done after the MRI.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- National Institutes of Health Clinical Center, 9000 Rockville Pike
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
- INCLUSION CRITERIA:
Plus Tinnitus Plus Hearing loss subjects.
- Adults, between the ages of 30 to 65 years.
- Are able to hear and perceive sounds used in the experiment in the range 250 Hz to 2 KHz and have high-frequency sensorineural hearing loss beginning no lower than 2 KHz.
- In good health and not currently taking certain medications regularly (e.g. antidepressants, antiseizure medications, antipsychotics, etc.).
- Experience tinnitus daily.
- Have had non-pulsatile tinnitus for at least 1 year.
- Have bilateral or bilateral with unilateral dominance tinnitus.
Minus Tinnitus Plus Hearing loss subjects.
- Adults, between the ages of 30 to 65 years.
- Are able to hear and perceive sounds used in the experiment in the range 250 Hz to 2 KHz and have high-frequency sensorineural hearing loss beginning no lower than 2 KHz.
- In good health and not currently taking certain medications regularly (e.g. antidepressants, antiseizure medications, antipsychotics, etc.).
- Have never or rarely (i.e. transient episodes experienced by virtually everyone) experienced tinnitus.
Minus Tinnitus Minus Hearing loss subjects or normal volunteers.
- Adults, between the ages of 30 to 65 years.
- Have normal hearing.
- In good health and not currently taking certain medications regularly (e.g. antidepressants, antiseizure medications, antipsychotics, etc.).
EXCLUSION CRITERIA:
- Subjects who have pacemakers, aneurysm clips, metallic prostheses or shrapnel fragments.
- Subjects incapable of giving informed consent.
- Subjects with a positive pregnancy test.
- Children below the age of 18 years.
- Subjects with hyperacusis or misophonia (hyper-sensitivity to loud noises).
- Subjects with mood disturbances such as depression or anxiety.
- Subjects with a history of temporomandibular joint problems or who present symptoms of pain and tenderness of the temporomandibular joint on examination.
Subjects may be excluded for the following reasons that may cause difficulty with interpretation of the imaging data:
- Subjects with mental or physical illnesses, other than tinnitus that may cause problems with participation in the study.
- Subjects with current uncontrolled hypertension, or significant past history of cardiovascular disease and diabetes melitus.
- Subjects with a history of head trauma with loss of consciousness, epilepsy, seizures, a history of chemotherapy (neurotoxic or ototoxic) and other medical conditions that may alter cerebral functioning.
- Subjects who are taking or have a history of taking recreational drugs or alcoholism.
- Subjects with unilateral or asymmetrical hearing loss who have not had (or cannot provide documentation of) comprehensive neuro-otologic workup will be excluded.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary hypothesis is that a network of brain regions, from auditory processing areas to emotional processing areas, contributes to, and modulates, tinnitus perception.
Time Frame: ongoing
|
ongoing
|
Collaborators and Investigators
Investigators
- Principal Investigator: Barry Horwitz, Ph.D., National Institute on Deafness and Other Communication Disorders (NIDCD)
Publications and helpful links
General Publications
- Mirz F, Gjedde A, Sodkilde-Jrgensen H, Pedersen CB. Functional brain imaging of tinnitus-like perception induced by aversive auditory stimuli. Neuroreport. 2000 Feb 28;11(3):633-7. doi: 10.1097/00001756-200002280-00039.
- Giraud AL, Chery-Croze S, Fischer G, Fischer C, Vighetto A, Gregoire MC, Lavenne F, Collet L. A selective imaging of tinnitus. Neuroreport. 1999 Jan 18;10(1):1-5. doi: 10.1097/00001756-199901180-00001.
- Mirz F, Gjedde A, Ishizu K, Pedersen CB. Cortical networks subserving the perception of tinnitus--a PET study. Acta Otolaryngol Suppl. 2000;543:241-3. doi: 10.1080/000164800454503.
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 060218
- 06-DC-0218
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Disorder
-
Bnai Zion Medical CenterUnknownSensorineural Hearing Loss (Disorder)Israel
-
Vanderbilt University Medical CenterWithdrawnCochlear Implants | Sensory-Neural Hearing Loss | Balance DisorderUnited States
-
University of ZurichCompleted
-
Eye & ENT Hospital of Fudan UniversityCompletedVestibular Disorder | Sudden Hearing LossChina
-
National Institute on Deafness and Other Communication...CompletedSensorineural Hearing Loss | Vestibular Disease | Hearing DisorderUnited States, Nigeria
-
Värmland County Council, SwedenEnrolling by invitationVestibular Disorder | Hearing Loss, Sensorineural, Severe | Hearing Loss, Sensorineural, ProfoundSweden
-
Alexandria UniversityRecruitingDevelopmental Language Disorder | Hearing Impaired ChildrenEgypt
-
University Hospital, GhentUniversitaire Ziekenhuizen KU Leuven; Jessa Hospital; Queen Fabiola Children's... and other collaboratorsCompletedVestibular Disorder | Hearing Impaired ChildrenBelgium
-
Father Flanagan's Boys' HomeRecruitingHearing Loss, Sensorineural | Vestibular DisorderUnited States
-
New York UniversityThe New York Eye & Ear InfirmaryActive, not recruitingHearing Loss, Sensorineural | Vestibular DisorderUnited States